Status:
UNKNOWN
Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation
Lead Sponsor:
Kolding Sygehus
Conditions:
Angina Pectoris
Eligibility:
All Genders
18-28 years
Phase:
PHASE4
Brief Summary
The study evaluate the absorption rate of different sublingual formulation of nitroglycerine (NTG) either in the form of available tablets or a new rapid absorbable gelation capsule formulation "NTG15...
Detailed Description
Ten healthy young volunteers are recruited,, and the experiments begin at 07:45 after an overneight fast. BMI and blod pressure are recorded and a catheter is inserted in an anticubical vein for blood...
Eligibility Criteria
Inclusion
- Normal healthy volunteers
- Must be able to swallow tablets
Exclusion
- Insulin dependent diabetes
- Thyroid disease
- any medial treatment
Key Trial Info
Start Date :
December 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 23 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03777605
Start Date
December 23 2018
End Date
December 23 2020
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kolfding Sygehus, SLB
Kolding, Denmark, 6000